Roth Capital Downgrades Uroplasty (UPI) to Neutral
Tweet
Share
E-mailGet Alerts UPI Hot Sheet
Price: $1.22 --0%
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Roth Capital downgraded Uroplasty (NASDAQ: UPI) from Buy to Neutral.
For more ratings news on Uroplasty click here and for the rating history of Uroplasty click here.
Shares of Uroplasty closed at $8.31 yesterday.
For more ratings news on Uroplasty click here and for the rating history of Uroplasty click here.
Shares of Uroplasty closed at $8.31 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Downgrades Limbach Holdings (LMB) to Underweight
- Goldman Sachs Downgrades Hysan Development Company Limited (14:HK) (HYSNY) to Sell
- Kepler Cheuvreux Downgrades Avantium N.V (AVTX:NA) to Reduce
Create E-mail Alert Related Categories
DowngradesRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
